ANTIDEPRESSANTS AND TEEN SUICIDE: AN ANALYSIS OF THE FDA'S REGULATION OF PHARMACEUTICALS FOR USE IN PEDIATRIC PATIENTS

ANTIDEPRESSANTS AND TEEN SUICIDE: AN ANALYSIS OF THE FDA'S REGULATION OF PHARMACEUTICALS FOR USE IN PEDIATRIC PATIENTS

This comment analyzes the FDA's historically lax approach to regulating antidepressants for children. Moreover, it suggests ways to improve the FDA's regulation of medication in pediatric populations by limiting off-label prescription. Gordon argues that even though off-label prescription...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Administrative law review 2005-07, Vol.57 (3), p.927-949
1. Verfasser: Gordon, Sarah D.
Format: Artikel
Sprache:eng
Schlagworte:
Antidepressants
Childhood mental disorders
Drug prescriptions
Drug regulation
Federal regulation
Medications
NOTES & COMMENTS
Pharmaceutical industry
Pharmaceutical preparations
Pharmacology
Prescription drugs
Serotonin agents
Suicide
Suicides & suicide attempts
Warnings
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This comment analyzes the FDA's historically lax approach to regulating antidepressants for children. Moreover, it suggests ways to improve the FDA's regulation of medication in pediatric populations by limiting off-label prescription. Gordon argues that even though off-label prescription is not regulated for adults, it should be regulated for pediatric populations because children are a unique group.
ISSN:0001-8368
2326-9154